• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素诱导的血小板减少症的独特免疫特征。

The unique immunological features of heparin-induced thrombocytopenia.

机构信息

Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.

Canadian Blood Services, Hamilton, ON, Canada.

出版信息

Br J Haematol. 2017 Apr;177(2):198-207. doi: 10.1111/bjh.14603. Epub 2017 Apr 3.

DOI:10.1111/bjh.14603
PMID:28369702
Abstract

Heparin-induced thrombocytopenia (HIT) is a serious drug reaction that leads to a decrease in platelet count and a high risk of thrombosis. HIT patients produce pathogenic immunoglobulin G (IgG) antibodies that bind to complexes of platelet factor-4 (PF4) and heparin. HIT immune complexes crosslink Fc-receptors resulting in platelet and monocyte activation. These events lead to the release of procoagulant chemokines and tissue factor, which together create an intensely prothrombotic state. HIT represents an atypical immune response because it has features of both T cell-dependent and T cell-independent mechanisms. The disorder is characterized by newly formed anti-PF4/heparin IgG antibodies, which are characteristic of a T cell-dependent mechanism; however, re-exposure to heparin, months after HIT, does not lead to a memory response, which is consistent with a T cell-independent mechanism. In this review, we discuss the immunobiological events that can explain these features, including the role for T cell-dependent and T cell-independent mechanisms in HIT antibody generation, the immunogenic characteristics of the PF4/heparin antigen, and the concept of a temporary loss in immune regulation contributing to the onset of HIT. We also present a novel immunobiological model to explain the atypical immune response that is characteristic of HIT.

摘要

肝素诱导的血小板减少症(HIT)是一种严重的药物反应,可导致血小板计数减少和血栓形成风险增加。HIT 患者会产生致病性免疫球蛋白 G(IgG)抗体,该抗体与血小板因子 4(PF4)和肝素的复合物结合。HIT 免疫复合物交联 Fc 受体,导致血小板和单核细胞活化。这些事件导致促凝趋化因子和组织因子的释放,共同导致强烈的促血栓形成状态。HIT 代表一种非典型的免疫反应,因为它具有 T 细胞依赖性和 T 细胞非依赖性机制的特征。该疾病的特征是新形成的抗 PF4/肝素 IgG 抗体,这是 T 细胞依赖性机制的特征;然而,HIT 发生数月后再次暴露于肝素不会导致记忆反应,这与 T 细胞非依赖性机制一致。在这篇综述中,我们讨论了可以解释这些特征的免疫生物学事件,包括 T 细胞依赖性和 T 细胞非依赖性机制在 HIT 抗体产生中的作用、PF4/肝素抗原的免疫原性特征以及免疫调节暂时丧失导致 HIT 发病的概念。我们还提出了一种新的免疫生物学模型来解释 HIT 特有的非典型免疫反应。

相似文献

1
The unique immunological features of heparin-induced thrombocytopenia.肝素诱导的血小板减少症的独特免疫特征。
Br J Haematol. 2017 Apr;177(2):198-207. doi: 10.1111/bjh.14603. Epub 2017 Apr 3.
2
[Diagnosis and treatment of heparin-induced thrombocytopenia (HIT) based on its atypical immunological features].基于非典型免疫特征的肝素诱导的血小板减少症(HIT)的诊断与治疗
Rinsho Ketsueki. 2016 Mar;57(3):322-32. doi: 10.11406/rinketsu.57.322.
3
[Anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia--review].[抗肝素/血小板第4因子抗体与肝素诱导的血小板减少症——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Apr;16(2):457-60.
4
Heparin-induced thrombocytopenia: an overview.肝素诱导的血小板减少症:概述
Blood Rev. 2002 Mar;16(1):77-80. doi: 10.1054/blre.2001.0189.
5
Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia.单核细胞介导的血小板激活促进肝素诱导的血小板减少症中的血栓形成。
Blood. 2016 Jan 28;127(4):464-72. doi: 10.1182/blood-2013-11-539262. Epub 2015 Oct 30.
6
Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.肝素诱导的血小板减少症:一种通过动态自身抗原组装/拆卸调节的自身免疫性疾病。
J Clin Apher. 2007 Feb;22(1):31-6. doi: 10.1002/jca.20109.
7
Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.肝素诱导的血小板减少症中针对大分子血小板因子4-肝素复合物的抗体:44例研究。
Thromb Haemost. 1995 Jan;73(1):21-8.
8
Heparin-induced thrombocytopenia.肝素诱导的血小板减少症。
Haematologica. 2000 Jan;85(1):72-81.
9
Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.膜表达的血小板因子 4 的生理变化:肝素诱导的血小板减少症的意义。
Thromb Res. 2010 Apr;125(4):e143-8. doi: 10.1016/j.thromres.2009.10.021.
10
Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies.肝素诱导的血小板减少症中的免疫机制:无免疫球蛋白M抗独特型抗体的证据。
Transfusion. 2009 Sep;49(9):1812-8. doi: 10.1111/j.1537-2995.2009.02205.x. Epub 2009 May 20.

引用本文的文献

1
Platelet signaling in immune landscape: comprehensive mechanism and clinical therapy.免疫格局中的血小板信号传导:综合机制与临床治疗
Biomark Res. 2024 Dec 31;12(1):164. doi: 10.1186/s40364-024-00700-y.
2
Genetic predisposition to vaccine-induced immune thrombotic thrombocytopenia.疫苗诱导的免疫性血栓性血小板减少症的遗传易感性。
Br J Haematol. 2025 Jan;206(1):387-388. doi: 10.1111/bjh.19885. Epub 2024 Nov 10.
3
The Crossroads of the Coagulation System and the Immune System: Interactions and Connections.凝血系统与免疫系统的交汇点:相互作用与关联。
Int J Mol Sci. 2023 Aug 8;24(16):12563. doi: 10.3390/ijms241612563.
4
Cloned antibodies from patients with HIT provide new clues to HIT pathogenesis.从 HIT 患者中克隆的抗体为 HIT 发病机制提供了新的线索。
Blood. 2023 Mar 2;141(9):1060-1069. doi: 10.1182/blood.2022017612.
5
Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT.单克隆和寡克隆抗血小板因子 4 抗体介导 VITT。
Blood. 2022 Jul 7;140(1):73-77. doi: 10.1182/blood.2021014588.
6
The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients.抗 PF4 抗体同种型和内源性糖胺聚糖的相关性及其与肺栓塞患者炎症生物标志物的关系。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221091770. doi: 10.1177/10760296221091770.
7
Elucidation of Cellular Contributions to Heparin-Induced Thrombocytopenia Using Omic Approaches.利用组学方法阐明细胞对肝素诱导的血小板减少症的作用。
Front Pharmacol. 2022 Jan 21;12:812830. doi: 10.3389/fphar.2021.812830. eCollection 2021.
8
Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin.抗PF4 VITT抗体是寡克隆性的,且可被肝素不同程度地抑制。
medRxiv. 2021 Sep 24:2021.09.23.21263047. doi: 10.1101/2021.09.23.21263047.
9
An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations.COVID-19 疫苗诱导的血栓性血小板减少综合征及部分管理建议的最新进展。
Molecules. 2021 Aug 18;26(16):5004. doi: 10.3390/molecules26165004.
10
To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia.是否形成血栓?这是一个问题——疫苗诱导的血栓性血小板减少症相关机制的见解。
J Thromb Haemost. 2021 Nov;19(11):2845-2856. doi: 10.1111/jth.15485. Epub 2021 Aug 23.